Prognostic or Therapeutic-The Role of Sentinel Lymph Node Biopsy in Contemporary Practice.
暂无分享,去创建一个
[1] A. Gesierich,et al. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial. , 2022, JAMA surgery.
[2] D. Schadendorf,et al. Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial , 2022, The Lancet.
[3] Taylor P Williams,et al. Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy , 2020, Annals of Surgical Oncology.
[4] Jeffrey E Gershenwald,et al. Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.
[5] A. Gesierich,et al. Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma , 2017, The New England journal of medicine.
[6] C. Berking,et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. , 2016, The Lancet. Oncology.
[7] R. Elashoff,et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. , 2014, The New England journal of medicine.